BioCision, the CoolPrep company, has expanded its management team with the appointment of industry veteran Hugh Douglas to the position of chief operating officer.

BioCision said that Douglas recently led Bridge4Bio, a global business consulting group and previously, he was managing director and president of Hoefer, a part of Harvard Bioscience.

Douglas was also vice president of the West Coast operations for Amersham Biosciences, a part of GE Healthcare.

The expansion of the BioCision’s corporate advisory board provides BioCision an additional set of experts with whom to consult, as the company expands its product offerings.

BioCision CEO Rolf Ehrhardt said the expansion of their management team and the addition of new members to top-notch corporate advisory board give the firm a wealth of experience to tap into as they continue to rapidly expand their product line of benchtop sample handling tools.

“Hugh Douglas’s experience in successfully managing high-growth start-ups will be an asset to our firm as we move forward,” Ehrhardt said.